Ledger.Open graph →
SEC Form D · filed February 3, 2011

Revance Therapeutics, Inc

Offering
$15.0M
Sold
$5.0M
Exemption
—
Industry
Pharmaceuticals
Location
NEWARK, CA
Type
—

People & firms on this filing (14)

Ron Eastman · Newark, CADirectorRichard Teal · Austin, TXDirectorFrank Kung · Newark, CADirectorToney Jennings · Austin, TXDirectorGregory J. Petro · Pittsburgh, PADirectorDan Beecroft · Boca Raton, FLDirectorDaniel M. Teal · Austin, TXDirectorPhyllis Gardner · Newark, CADirectorRobert Byrnes · Newark, CADirectorBlake Beecroft · Boca Raton, FLDirectorVicente Trelles · Newark, CADirectorJoel R. Beaudin · North River, NYExec · DirectorJim Glasheen · Newark, CADirectorL. D. Browne · Newark, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗